Bacillus Calmette–Guérin and anti-PD-L1 combination therapy boosts immune response against bladder cancer

Bacillus Calmette–Guérin and anti-PD-L1 combination therapy boosts immune response against bladder cancer

Yonghua Wang,1 Jing Liu,2 Xuecheng Yang,1 Yanan Liu,1 Yong Liu,1 Yanjiang Li,1 Lijiang Sun,1 Xiaokun Yang,1 Haitao Niu1 1Department of Urology, 2Department of Pediatrics, The Affiliated Hospital of Qingdao University, Qingdao 266000, People’s Republic of China Background: Programmed deat...

Full description

Bibliographic Details
Main Authors:	Wang Y, Liu J, Yang X, Liu Y, Li Y, Sun L, Niu H
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-05-01
Series:	OncoTargets and Therapy
Subjects:	BCG PD-L1 bladder cancer immunotherapy combination therapy
Online Access:	https://www.dovepress.com/bacillus-calmette-guerin-and-anti-pd-l1-combination-therapy-boosts-imm-peer-reviewed-article-OTT

Similar Items

Remodels the Immunosuppressive Tumor Microenvironment by Combination of Bacillus Calmette–Guérin and Anti-PD-L1 in an Orthotopic Triple-Negative Breast Cancer Mouse Model
by: Lu Y, et al.
Published: (2021-03-01)

Risk factor assessment in high-risk, bacillus Calmette–Guérin-treated, non-muscle-invasive bladder cancer
by: Holz S, et al.
Published: (2017-09-01)

Phenotypic and Genotypic Drug Susceptibility Assessment of Mycobacterium bovis Bacillus Calmette-Guérin Clinical Strains
by: Sisco MC, et al.
Published: (2021-02-01)

Levofloxacin-Loaded Nanosonosensitizer as a Highly Efficient Therapy for Bacillus Calmette-Guérin Infections Based on Bacteria-Specific Labeling and Sonotheranostic Strategy
by: Li G, et al.
Published: (2021-09-01)

Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
by: Guallar-Garrido S, et al.
Published: (2020-02-01)

Managing the adverse events of intravesical bacillus Calmette–Guérin therapy
by: Decaestecker K, et al.
Published: (2015-10-01)

The efficacy and safety of intravesical gemcitabine vs Bacille Calmette-Guérin for adjuvant treatment of non-muscle invasive bladder cancer: a meta-analysis
by: Ye Z, et al.
Published: (2018-08-01)

Bacillus Calmette–Guérin and Bladder Cancer
by: Azad H.A. Razack
Published: (2007-10-01)

Bacillus Calmette-Guerin vaccine and bladder cancer incidence: Scoping literature review and preliminary analysis
by: Sabrina Trigo, et al.
Published: (2021-03-01)

Mechanism of Genetically-Regulated Response to Bacillus- Calmette Guérin Immunotherapy for Bladder Cancer
by: Hakeem Sam, et al.
Published: (2020-12-01)

Sternal osteomyelitis after bacillus Calmette-Guérin vaccination
by: Rolandas Selvestravičius, et al.
Published: (2016-09-01)

Bacillus Calmette–Guérin Immunotherapy for Cancer
by: Fabíola Cardillo, et al.
Published: (2021-05-01)

Interstitial pneumonitis secondary to intravesical bacillus calmette-guerin for carcinoma in-situ of the bladder
by: Eric K. Diner, et al.
Published: (2004-10-01)

Combined Application of Nivolumab and Intravesical Bacillus Calmette-Guérin Led to Acute-Onset Type 1 Diabetes
by: Koichi Fujiu, et al.
Published: (2019-06-01)

Bladder Contracture – A Rare and Serious Side Effect of Intravesical Bacillus Calmette-Guérin Therapy
by: Cindy Garcia, et al.
Published: (2016-01-01)

Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer
by: Florus C. de Jong, et al.
Published: (2021-03-01)

Microscopic detection of bacillus Calmette–Guérin mycobacteria in bladder biopsy using fluorescence in situ hybridization
by: A. Loukil, et al.
Published: (2021-01-01)

Tuberculous Granuloma in the Scrotal Skin After Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: A Case Report
by: Hiroshi Shimura, et al.
Published: (2017-02-01)

Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer
by: Jungyo Suh, et al.
Published: (2021-08-01)

A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette–Guérin (BCG) against Mycobacterium tuberculosis
by: Sudeep Kumar Maurya, et al.
Published: (2020-09-01)

The Adverse Events, Signs, and Management of Neonatal Bacillus Calmette-Guérin Vaccine Overdose
by: Ali Abdullah Al-Maqbali, et al.
Published: (2016-07-01)

Breast abscess due to Bacillus Calmette-Guérin
by: Aurélien Dinh, et al.
Published: (2017-06-01)

Bacillus Calmette-Guerin (BCG): the adroit vaccine
by: Oluwafolajimi A. Adesanya, et al.
Published: (2021-02-01)

Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?
by: Renata Monteiro-Maia, et al.
Published: (2014-09-01)

Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency
by: Ewa Anna Bernatowska, et al.
Published: (2007-05-01)

Use of the Human Vaccine, Mycobacterium bovis Bacillus Calmette Guérin in Deer
by: Mitchell V. Palmer, et al.
Published: (2018-10-01)

Disseminated bacillus calmette guerin disease in a twin infant with severe combined immunodeficiency disease
by: Hema Mittal, et al.
Published: (2014-01-01)

The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy
by: Patricia Méndez-Samperio
Published: (2019-06-01)

Multiparametric ultrasound findings of tuberculous orchitis following bacillus Calmette-Guérin therapy
by: Rumman Ahmed, MB BS, BSc (Hons), FRCR, et al.
Published: (2017-12-01)

Methylation status as a predictor of intravesical Bacillus Calmette-Guérin (BCG) immunotherapy response of high grade non-muscle invasive bladder tumor
by: Petr Husek, et al.
Published: (2017-06-01)

Antibacterial activities of gold and silver nanoparticles against <it>Escherichia coli</it> and bacillus Calmette-Guérin
by: Zhou Yan, et al.
Published: (2012-05-01)

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review
by: Stefanie Schmidt, et al.
Published: (2020-07-01)

Establishment of Three-Dimensional Bioprinted Bladder Cancer-on-a-Chip with a Microfluidic System Using Bacillus Calmette–Guérin
by: Jung Hoon Kim, et al.
Published: (2021-08-01)

Reporte de dos casos de linfadenitis supurada causada por bacilo de Calmette-Guerin tratados con interferón gamma recombinante Report of two cases of suppurated lymphadenitis caused by Bacillus Calmette-Guerin treated with recombinant γ-interferon
by: Gladys Abreu Suárez, et al.
Published: (2008-09-01)

A severe complication of intravesical bacillus Calmette-Guerin: An effect of different strains
by: Li Sian Low, et al.
Published: (2021-05-01)

Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
by: Zongren Wang, et al.
Published: (2018-11-01)

A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer
by: Fan Z, et al.
Published: (2019-03-01)

DISSEMINATED BACILLUS-CALMETTE-GUÉRIN INFECTIONS AND PRIMARY IMMUNODEFICIENCY DISORDERS IN SINGAPORE: A SINGLE CENTER 15-YEAR RETROSPECTIVE REVIEW
by: Rina Yue Ling Ong, et al.
Published: (2020-08-01)

Pattern of cytokine and chemokine production by THP-1 derived macrophages in response to live or heat-killed Mycobacterium bovis bacillus Calmette-Guérin Moreau strain
by: Periela da Silva Sousa-Vasconcelos, et al.
Published: (2015-09-01)

Determinants of Bacille Calmette-Guérin scarification in Danish children
by: Trine Mølbæk Jensen, et al.
Published: (2021-01-01)